Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance? Authors' Reply.

Saved in:
Bibliographic Details
Title: Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance? Authors' Reply.
Authors: Lin YS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan., Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan., Lee TY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 May; Vol. 63 (10), pp. 1429-1430. Date of Electronic Publication: 2026 Mar 17.
Publication Type: Editorial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70628